Which immunotherapies are expected to reach blockbuster status in 2016?

Which companies have PD-1/PD-L1 inhibitors in clinical development?

Which cancer vaccine was awarded the UK's ‘Promising Innovative Medicine' designation in September 2014?

Which immunotherapies are in clinical trials in combination with Brisol-Myers' Squibb's Yervoy (ipilimumab)?

Which companies have development agreements with Incyte for combinations with INCB24360?

Published by Espicom - experts in the healthcare field for over 30 years, ‘Advances in Cancer Immunotherapy 2014’ brings together a range of often difficult to source information in one single, convenient and comprehensive publication.